Report

plasma protein therapeutics market

Plasma Protein Therapeutics Market based on Type (Coagulation Factors, Immunoglobulins, Albumins, and C1 esterase Inhibitors), Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic, Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Others) and Geography – Global Forecast to 2027

pages Pages: 67
tables Tables: 78
charts Charts: 48
country Regions/Countries: 4 / 10
compaines Companies: 10
enqhours Enquiry Hours: 10
  • Get Free 10% Customization in this Report

COVID - 19

Covid impact updated reports at special price

Plasma is a protein-rich fluid and has a vital role in clotting and providing immunity to diseases. By separating the proteins from plasma, they can be used in medical therapies, such as autoimmune, immune deficiencies, neurological and bleeding disorders. Plasma protein therapies cure well-defined medical conditions by replacing the deficient or lost proteins in plasma. Plasma protein therapeutics consists of biological medicines, either infused or injected to treat life-threatening, chronic, and genetic diseases. The rising advent of new plasma-derived therapies is the key propellant factor for the plasma protein therapeutics market growth. Further, the increasing number of life-threatening diseases involving immune or neurological systems and other diseases such as rabies, tetanus, hepatitis, A&B, and varicella are the other key factors likely to foster the plasma protein therapeutics market growth. Apart from that, the restricted rules and regulations for handling plasma protein products are impeding market growth. The Plasma Protein Therapeutics Market is estimated to grow at the rate of 8.98% CAGR by 2027.     

Research Methodology:

The Plasma Protein Therapeutics Market has been analyzed by utilizing the optimum combination of secondary sources and in-house methodology and a unique balance of primary insights. The real-time valuation of the market is an integral part of our forecasting and market sizing methodology. Industry experts and our primary participants have helped to compile related aspects with accurate parametric estimations for a complete study. The primary participants share is given below:

Plasma Protein Therapeutics Market

Plasma Protein Therapeutics Market based on Type

  • Coagulation Factors
  • Immunoglobulins
  • Albumins
  • C1 esterase Inhibitors

Plasma Protein Therapeutics Market based on Application

  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Idiopathic Thrombocytopenic
  • Purpura
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Others

 Plasma Protein Therapeutics Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

As per the plasma protein therapeutics market by type, the market is divided into Coagulation Factors, Immunoglobulins, Albumins, and C1 esterase Inhibitors. Among them, the albumin segment is projected to obtain a significant share over the forecast period. This is driven by an enhanced diagnosis of hypoalbuminemia disease caused by liver cirrhosis and hepatitis B. Substantial demand and usage in China, which is the major market for albumin, is expected to boost the market growth further. Patients suffering from medium to severe hemophilia need clotting factor VIII as a preventive or on-demand therapy. The above factors are supporting the segment growth.

As in the plasma protein therapeutics market for application, the applications of the plasma protein therapeutics include Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic, Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Others. The hemophilia segment is anticipated to hold a substantial share in the market. The substantial share of this segment is attributed to the rising elderly population and the surging number of patients suffering from life-threatening diseases. Also, the shifting lifestyles, such as changing food habits and adopting sedentary lifestyles specifically in the urban areas, lead to diseases.

Further, the geographical plasma protein therapeutics market is categorized into North America, Europe, Asia Pacific, and the rest of the world. The North American region is placed at the top of the market share. This is due to the rising capital income, increasing modern technologies, and introduction of innovative therapies expected to drive the plasma protein therapeutics market growth in the region.

Quality and advancements in plasma therapeutics have been the favorable drivers of the global plasma protein therapeutics market to enhance the quality of life of patients and assure donor safety. Plasma obtained through apheresis technology or complete blood donation procedure can either be gathered or bifurcated into plasma protein products which comprise one or more purified plasma protein or transferred directly to patients.

This report provides the few notable vendors of the plasma protein therapeutics market include Takeda Pharmaceutical Company Ltd., China Biologics Products Holdings, Bio Products Laboratory Ltd., ADMA Biologics, Inc., CSL Behring LLC, HEMA Biologics LLC,  Biotest AG, Grifols S.A., Kedrion S.P.A., Inc., and Baxter International Ltd.

Hence, plasma protein has increased majorly in medical applications in the past few years. Along with the advancements in technology, the procedure of separating the protein from plasma has become highly cost-efficient and cost-saving, which has increased the importance of plasma protein therapies.

  • This report delivers an overall analysis of the present and future market trends and dynamics in the plasma protein therapeutics market.
  • Geographically, the market report analyzes the regions such as North America, Europe, Asia Pacific, and the rest of the world.
  • This report includes a comprehensive quantitative analysis of the present market and projections, which helps to identify the emerging market opportunities.
  • This report also includes the significant plasma protein therapeutics market players and their dynamic strategies, expansions, mergers, acquisitions, and new product launches.

 

  1. Executive Summary
  2. Industry Outlook
    1. Industry Overview
    2. Industry Trends
  3. Market Snapshot
    1. Market Definition
    2. Market Outlook
      1. Porter Five Forces
    3. Related Markets
  4. Market characteristics
    1. Market Overview
    2. Market Segmentation
    3. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    4. DRO - Impact Analysis
  5. Type: Market Size & Analysis
    1. Overview
    2. Coagulation Factors
    3. Immunoglobulins
    4. Albumins
    5. C1 esterase Inhibitors
  6. Application: Market Size & Analysis
    1. Overview
    2. Hemophilia
    3. Primary Immunodeficiency Disorder
    4. Idiopathic Thrombocytopenic
    5. Purpura
    6. Secondary Immunodeficiency
    7. Hereditary Angioedema
    8. Others
  7. Geography: Market Size & Analysis
    1. Overview
    2. North America
    3. Europe
    4. Asia Pacific
    5. Rest of the World
  8. Competitive Landscape
    1. Competitor Comparison Analysis
    2. Market Developments
      1. Mergers and Acquisitions, Legal, Awards, Partnerships
      2. Product Launches and execution
  9. Vendor Profiles
    1. Takeda Pharmaceutical Company Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    2. China Biologics Products Holdings
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    3. Bio Products Laboratory Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    4. ADMA Biologics, Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    5. CSL Behring LLC
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    6. HEMA Biologics LLC
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    7. Biotest AG
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    8. Grifols S.A.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    9. Kedrion S.P.A., Inc.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
    10. Baxter International Ltd.
      1. Overview
      2. Financial Overview
      3. Product Offerings
      4. Developments
      5. Business Strategy
  10. Analyst Opinion
  11. Annexure
    1. Report Scope
    2. Market Definitions
    3. Research Methodology
      1. Data Collation and In-house Estimation
      2. Market Triangulation
      3. Forecasting
    4. Report Assumptions
    5. Declarations
    6. Stakeholders
    7. Abbreviations

TABLE 1.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 2.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR COAGULATION FACTORS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 3.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR IMMUNOGLOBULINS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 4.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR ALBUMINS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 5.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR C1 ESTERASE INHIBITORS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 6.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 7.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR HEMOPHILIA, 2021-2027 (USD BILLION)

TABLE 8.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR PRIMARY IMMUNODEFICIENCY DISORDER, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 9.           GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR IDIOPATHIC THROMBOCYTOPENIC, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 10.         GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR PURPURA, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 11.         GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR SECONDARY IMMUNODEFICIENCY, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 12.         GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR HEREDITARY ANGIOEDEMA, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 13.         GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)

TABLE 14.         NORTH AMERICA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 15.         NORTH AMERICA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 16.         NORTH AMERICA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 17.         U.S PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 18.         U.S PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 19.         CANADA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 20.         CANADA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 21.         EUROPE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 22.         EUROPE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 23.         EUROPE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, APPLICATION, 2021-2027 (USD BILLION)

TABLE 24.         GERMANY PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 25.         GERMANY PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 26.         U.K PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 27.         U.K PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 28.         FRANCE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 29.         FRANCE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 30.         ITALY PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 31.         ITALY PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 32.         SPAIN PLASMA PROTEIN THERAPEUTICS  MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 33.         SPAIN PLASMA PROTEIN THERAPEUTICS  MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 34.         ROE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 35.         ROE PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 36.         ASIA PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)

TABLE 37.         ASIA PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 38.         ASIA PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 39.         CHINA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 40.         CHINA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 41.         INDIA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 42.         INDIA PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 43.         JAPAN PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 44.         JAPAN PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 45.         REST OF APAC PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 46.         REST OF APAC PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 47.         REST OF WORLD PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)

TABLE 48.         REST OF WORLD PLASMA PROTEIN THERAPEUTICS MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)

TABLE 49.         TAKEDA PHARMACEUTICAL COMPANY LTD: FINANCIALS          

TABLE 50.         TAKEDA PHARMACEUTICAL COMPANY LTD: PRODUCTS & SERVICES    

TABLE 51.         TAKEDA PHARMACEUTICAL COMPANY LTD: RECENT DEVELOPMENTS   

TABLE 52.         CHINA BIOLOGICS PRODUCTS HOLDINGS: FINANCIALS          

TABLE 53.         CHINA BIOLOGICS PRODUCTS HOLDINGS: PRODUCTS & SERVICES     

TABLE 54.         CHINA BIOLOGICS PRODUCTS HOLDINGS: RECENT DEVELOPMENTS   

TABLE 55.         BIO PRODUCTS LABORATORY LTD: FINANCIALS          

TABLE 56.         BIO PRODUCTS LABORATORY LTD: PRODUCTS & SERVICES     

TABLE 57.         BIO PRODUCTS LABORATORY LTD: RECENT DEVELOPMENTS   

TABLE 58.         ADMA BIOLOGICS, INC: FINANCIALS   

TABLE 59.         ADMA BIOLOGICS, INC: PRODUCTS & SERVICES         

TABLE 60.         ADMA BIOLOGICS, INC: RECENT DEVELOPMENTS        

TABLE 61.         CSL BEHRING LLC: FINANCIALS           

TABLE 62.         CSL BEHRING LLC: PRODUCTS & SERVICES     

TABLE 63.         CSL BEHRING LLC: RECENT DEVELOPMENTS    

TABLE 64.         HEMA BIOLOGICS LLC: FINANCIALS    

TABLE 65.         HEMA BIOLOGICS LLC: PRODUCTS & SERVICES           

TABLE 66.         HEMA BIOLOGICS LLC: RECENT DEVELOPMENTS         

TABLE 67.         BIOTEST AG: FINANCIALS       

TABLE 68.         BIOTEST AG: PRODUCTS & SERVICES  

TABLE 69.         BIOTEST AG: RECENT DEVELOPMENTS

TABLE 70.         GRIFOLS S.A.: FINANCIALS     

TABLE 71.         GRIFOLS S.A.: PRODUCTS & SERVICES

TABLE 72.         GRIFOLS S.A.: RECENT DEVELOPMENTS          

TABLE 73.         KEDRION S.P.A., INC: FINANCIALS      

TABLE 74.         KEDRION S.P.A., INC: PRODUCTS & SERVICES

TABLE 75.         KEDRION S.P.A., INC: RECENT DEVELOPMENTS           

TABLE 76.         BAXTER INTERNATIONAL LTD: FINANCIALS     

TABLE 77.         BAXTER INTERNATIONAL LTD: PRODUCTS & SERVICES

TABLE 78.         BAXTER INTERNATIONAL LTD: RECENT DEVELOPMENTS

Research Framework

Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Primary & Secondary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting
Methodology

Market related information is congregated from both primary and secondary sources.

Primary sources

Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

Secondary sources

Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

outicon

Plasma Protein Therapeutics Market based on Type (Coagulation Factors, Immunoglobulins, Albumins, and C1 esterase Inhibitors), Application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic, Purpura, Secondary Immunodeficiency, Hereditary Angioedema, and Others) and Geography – Global Forecast to 2027
Interested in this report?
Get your FREE sample now!
DOWNLOAD NOW

Select User License

$
Request For Sample Report
Enquire Before Buying

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer 10% worth of FREE customization at the time of purchase

Speak to our analyst
Related Reports
Card image cap
Genital Herpes Treatment Market by Type of Drugs (Acyclovir,...
$ 4000
Card image cap
Compounding Pharmacy Market by Therapeutic Areas (Hormone Re...
$ 4000
Card image cap
Attention Deficit Hyperactivity Market by Drug Type (Stimula...
$ 4000
Card image cap
Heparin Sales Market By Type (Low Molecular Weight Heparin, ...
$ 4000
Card image cap
Vaccine Market By Technology Type (Recombinant, Conjugate Va...
$ 4000
Card image cap
Yeast Infection Market based on Pathogen Type (Candida albic...
$ 4000